title: [Pancreatitis and inappropriate ADH secretion syndrome associated with amiodarone].
abstract: We describe a case of hepatotoxicity, pancreatitis and inappropriate ADH secretion syndrome developed in a patient receiving chronic amiodarone treatment, not related to other causes. Hepatic toxicity is a well known condition. Inappropriate ADH secretion syndrome has not been described yet and there has been a single case-report of pancreatitis in the literature reviewed.
authors.affiliation: Servicio de Medicina Interna I, Hospital General Gregorio Marañón Madrid.
authors.forename: A I
authors.initials: AI
authors.lastname: Muñoz Ruiz
authors.forename: A
authors.initials: A
authors.lastname: Calvo Elipe
authors.forename: E
authors.initials: E
authors.lastname: Guerrero Vega
authors.forename: J J
authors.initials: JJ
authors.lastname: Gorgojo Martínez
authors.forename: E
authors.initials: E
authors.lastname: Vera López
authors.forename: C
authors.initials: C
authors.lastname: Gilsanz Fernández
mesh_terms: D000368:Aged; D000638:Amiodarone / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000188:drug therapy; D056486:Chemical and Drug Induced Liver Injury / Q000150:complications / Q000209:etiology; D006801:Humans; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced* / Q000150:complications; D008297:Male; D010195:Pancreatitis / Q000139:chemically induced* / Q000150:complications
chemical_list: D000889:Anti-Arrhythmia Agents; D000638:Amiodarone
vernacular_title: Pancreatitis y síndrome de secreción inadecuada de ADH asociados a amiodarona.